IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00839-07v1
75/12/5877    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Briles, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Briles, D. E.

 Previous Article  |  Next Article 

Infection and Immunity, December 2007, p. 5877-5885, Vol. 75, No. 12
0019-9567/07/$08.00+0     doi:10.1128/IAI.00839-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation{triangledown}

Jie Li,1 David T. Glover,1 Alexander J. Szalai,1,2 Susan K. Hollingshead,1 and David E. Briles1,3*

Departments of Microbiology,1 Medicine,2 Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama3

Received 18 June 2007/ Returned for modification 30 August 2007/ Accepted 27 September 2007

Pneumococcal surface protein A (PspA) and PspC are important virulence factors. Their absence has been shown to allow improved clearance of pneumococci from the blood of mice and to decrease pneumococcal virulence. In the presence of antibody and complement, pneumococci attach to erythrocytes in a process called immune adherence (IA), which facilitates their delivery to, and eventual phagocytosis by, macrophages. It is not known, however, if PspA and PspC affect IA. Using PspA and/or PspC isogenic mutants and complement-deficient mouse sera, we demonstrated that absence of PspA allows greater deposition of C1q and thus increased classical-pathway-mediated C3 deposition. In the absence of both PspA and PspC, there is also a major increase in C1q-independent C3 deposition through the alternative pathway. The latter was observed even though absence of PspC alone did not have a major effect on alternative-pathway-dependent complement deposition. The enhanced complement C3 deposition realized in the absence of PspA alone and in the absence of PspA and PspC resulted in both greatly increased IA to human erythrocytes and improved transfer of pneumococci from erythrocytes to phagocytes. These data provide new insight into how PspA and PspC act in synergy to protect pneumococci from complement-dependent clearance during invasive infection.


* Corresponding author. Mailing address: Alabama at Birmingham, BBRB 658, 1530 3rd Ave. S., Birmingham, AL 35294-2170. Phone: (205) 934-6595. Fax: (205) 934-0605. E-mail: dbriles{at}uab.edu

{triangledown} Published ahead of print on 8 October 2007.

Editor: A. Camilli


Infection and Immunity, December 2007, p. 5877-5885, Vol. 75, No. 12
0019-9567/07/$08.00+0     doi:10.1128/IAI.00839-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.